Bergen Brunswig Reports Record Annual Earnings and Revenue
- Share via
ORANGE — Bergen Brunswig Corp. posted record earnings and revenue for the fiscal year ended Sept. 30, the distributor of pharmaceuticals and medical surgical supplies said Thursday.
Net income rose 15.6% to $73.9 million, or $1.83 per share, from $63.9 million, or $1.61 per share, for the previous year. Revenue climbed nearly 18%, outpacing the company’s top two competitors, said Robert E. Martini, chairman and chief executive. Revenue totaled $9.9 billion, up from $8.4 billion.
For the fourth quarter, the company earned $18.3 million, or 45 cents a share, a 16.6% increase over the $15.7 million, or 39 cents a share, earned a year ago. Revenue climbed more than 18% to $2.6 billion from $2.2 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
